SOURCES:
World Health Organization: “Statement on the fifteenth meeting of the Emergency Committee of the International Health Regulations (2005) in relation to the pandemic of coronavirus disease (COVID-19)”.
Big Cities Health Coalition: press briefing, May 2, 2023.
US Department of Health and Human Services: “COVID-19 Public Health Emergency (PHE)”, “HHS Office for Civil Rights Announces the Expiration of COVID-19 Public Health Emergency HPAA Notifications of Enforcement Discretion”.
US Drug Enforcement Administration: “Statement by DEA Administrator Anne Milgram on COVID-19 Telemedicine Flexibilities for Prescribing Controlled Drugs.”
Medicare.gov: “Medicare and coronavirus.”
CMS.gov: “The Reduced Inflation Act reduces health care costs for millions of Americans.”
Morbidity and Mortality Weekly Report (MMWR): “COVID-19 Surveillance After Expiration of Public Health Emergency Declaration – United States, May 11, 2023.”
Kaiser Family Foundation: “Commercialization of COViD-19 Vaccines, Treatments, and Tests: Implications for Access and Coverage.”
Rajendram Rajnarayanan, PhD, assistant dean for research, associate professor, New York Institute of Technology College of Osteopathic Medicine at Arkansas State University, Jonesboro.
William Schaffner, MD, infectious disease specialist, professor of preventive medicine and health policy, Vanderbilt University, Nashville.
Anne N. Sosin, Policy Fellow, Nelson A. Rockefeller Center at Dartmouth College, Hanover, NH.
Meagan Fitzpatrick, PhD, assistant professor of medicine, University of Maryland School of Medicine, Baltimore.
—————————————————-
Source link